Clinical Care Options News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC

Even if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a survival benefit over chemotherapy alone, follow-up analyses of PAPILLON and MARIPOSA-2 showed.

United statesUniversity of virginiaComunidad autonoma de catalunaMaria rosario garcia campeloRyand gentzlerEnriqueta felipMerck seronoAntonio passaroDaiichi sankyoZofia piotrowskaEli lillySociety for immunotherapy of cancerJazz pharmaceuticalsUniversity hospitala coruEuropean institute of oncologyJanssen pharmaceuticals

9 new independent advisers to CDC publicly promoted vaccines or took money from pharma — or both – NaturalNews com

9 new independent advisers to CDC publicly promoted vaccines or took money from pharma — or both – NaturalNews com
naturalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalnews.com Daily Mail and Mail on Sunday newspapers.

United statesStanford schoolColorado schoolStanford universityNew yorkGeorge kuchelDenise jamiesonAlbert shawJoshua salomonBrenda balettiNoel brewerHelen keipp talbotMary hollandAstellas pharmaSanofi pasteurEdwin asturias

Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years | Public Health | JAMA

This study uses data from 3 prospective cohort studies conducted in the US to assess vaccine effectiveness of bivalent COVID-19 vaccines against SARS-CoV-2 infe

United statesNorth carolinaUniversity of arizonaSanofi pasteurLeorar feldsteinBriggs hagenArk biopharmaBurroughs wellcome fundFlorida firefighter cancer initiativeFlu labFlorida department of healthTexas pediatric societyNational institute of allergyInstitute incKaiser foundation hospitalsCommunity vaccine effectiveness

Adjuvant Pembrolizumab Significantly Prolongs OS vs Placebo in ccRCC

Treatment with adjuvant pembrolizumab significantly improved overall survival vs placebo in patients with clear cell renal cell carcinoma.

United statesDana farber cancer instituteBristol myers squibbNancy kohlbergToni choueiriRoche genentechCalithera biosciencesSanofi aventisMichaelj hennessy associatesGilead sciencesInfinity pharmaceuticalsLank centerKidney cancer programMedicine at harvard medical schoolFoundation medicineNavinata health

Neoadjuvant Durvalumab Plus Chemo Boosts pCR Vs Chemo Alone in Gastric/GEJ Cancers Regardless of Region

Durvalumab plus neoadjuvant FLOT improved pCR vs chemotherapy alone in patients with resectable gastric and GEJ cancers, irrespective of region.

United statesDurvalumab imfinziMerck seronoEli lillyGenentech rocheAmerisource bergenBasilea pharmaceuticaYelena janjigianPeerview instituteResearch to practiceMichaelj hennessy associatesZymeworks incGuardant health incGene pharma incParadigm medical communicationsLynx health